Rozerem Tablet, Film Coated
Product Images NDC 64764-805

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rozerem (NDC 64764-805). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Rozerem 01)

Chemical structure of ramelteon, the active ingredient in Rozerem 8 mg film-coated tablets by Takeda Pharmaceuticals America, Inc. The diagram illustrates the molecular structure with labeled atoms and bonds.*

FDA Label Image

Principal Display Panel (8 mg Bottle Label)

Label for Rozerem (ramelteon) 8 mg film-coated tablets, containing 30 tablets per bottle. The label includes storage instructions, distributor information (Takeda Pharmaceuticals America, Inc.), and a barcode. It also advises dispensing with a medication guide and notes the prescription-only status.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.